Experience of nivolumab and pembrolizumab in metastatic non-small cell lung cancer in routine clinical practice (mNSCLC.). F: women. M: men. Squ: squamous cell ...

Global burden of prostate cancer in 38 OECD countries and its trend from 1990-2021: An Insight from the Global Burden of Disease study 2021. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

In one patient, cell-free RNA markers of small-cell transformation diminished following chemotherapy, reflecting a shift in tumor state. For samples unrelated to cancer, RNA from mRNA vaccines was ...

Defining a New Lung Cancer Subtype: Atypical Small Cell Carcinoma Small cell lung ... The new subtype appears to arise through a transformation of lower-grade neuroendocrine tumors (pulmonary ...

There are two main types of lung cancer. Small-cell lung cancer (SCLC), sometimes called small-cell carcinoma, causes about 10%-15% of all lung cancer. Non-small-cell lung cancer (NSCLC ...

Changes in a gene’s DNA sequence drive the transformation of healthy cells into cancerous ones, and this new treatment targets the most common of those mutations in non-small-cell lung cancer. “ ...

Small-cell lung cancer treatment often includes medication like chemotherapy or immunotherapy. Usually, doctors will treat this type of cancer with a combination of medication and other types of ...